Kovai Medical Center and Hospital Limited (BOM:523323)
India · Delayed Price · Currency is INR 6,039.50
-34.60 (-0.57%)
At close: Aug 21, 2026
BOM:523323 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 16,430 | 15,856 | 13,711 | 12,196 | 10,197 | 9,053 | |
Revenue Growth | 14.90% | 15.65% | 12.43% | 19.59% | 12.64% | 31.14% |
Cost of Revenue | 8,502 | 8,231 | 7,074 | 5,968 | 5,060 | 4,446 |
Gross Profit | 7,928 | 7,625 | 6,637 | 6,228 | 5,138 | 4,608 |
Selling, General & Admin | 2,442 | 2,374 | 2,018 | 1,845 | 1,582 | 52.22 |
Other Operating Expenses | 866.78 | 813.25 | 753.45 | 961.81 | 848.63 | 1,978 |
Operating Expenses | 4,461 | 4,282 | 3,747 | 3,728 | 3,322 | 2,884 |
Operating Income | 3,467 | 3,344 | 2,890 | 2,499 | 1,816 | 1,724 |
Interest Expense | -307.76 | -319.33 | -326.39 | -327.5 | -399.33 | -428.66 |
Interest & Investment Income | 209.88 | 209.88 | 183.17 | 161.19 | 99.26 | 87.87 |
Other Non Operating Income (Expenses) | 61.41 | 44.76 | 37.5 | 45.92 | 58.03 | 33.24 |
EBT Excluding Unusual Items | 3,431 | 3,279 | 2,784 | 2,379 | 1,574 | 1,416 |
Gain (Loss) on Sale of Assets | -22.1 | -22.1 | -8.69 | -3.23 | -21.66 | -9.33 |
Pretax Income | 3,408 | 3,257 | 2,776 | 2,376 | 1,552 | 1,407 |
Income Tax Expense | 845.27 | 812.31 | 686.07 | 578.26 | 394.54 | 364.18 |
Net Income | 2,563 | 2,445 | 2,089 | 1,797 | 1,158 | 1,043 |
Net Income to Common | 2,563 | 2,445 | 2,089 | 1,797 | 1,158 | 1,043 |
Net Income Growth | 16.29% | 17.00% | 16.25% | 55.25% | 11.04% | 34.21% |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 11 |
Shares Change | 0.00% | - | - | - | - | - |
EPS (Basic) | 234.25 | 223.41 | 190.96 | 164.26 | 105.80 | 95.28 |
EPS (Diluted) | 234.25 | 223.41 | 190.96 | 164.26 | 105.80 | 95.28 |
EPS Growth | 16.29% | 17.00% | 16.25% | 55.25% | 11.04% | 34.21% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 1,099 | -184.92 | 2,057 | 1,355 | 1,625 |
Free Cash Flow Per Share | - | 100.42 | -16.90 | 188.00 | 123.85 | 148.53 |
Dividend Per Share | - | 15.000 | 10.000 | 10.000 | 5.000 | 3.000 |
Dividend Growth | - | 50.00% | 0% | 100.00% | 66.67% | 0% |
Gross Margin | 48.25% | 48.09% | 48.41% | 51.07% | 50.38% | 50.90% |
Operating Margin | 21.10% | 21.09% | 21.08% | 20.49% | 17.81% | 19.04% |
Profit Margin | 15.60% | 15.42% | 15.24% | 14.74% | 11.35% | 11.52% |
Free Cash Flow Margin | - | 6.93% | -1.35% | 16.87% | 13.29% | 17.95% |
EBITDA | 4,524 | 4,375 | 3,817 | 3,372 | 2,660 | 2,534 |
EBITDA Margin | 27.53% | 27.59% | 27.84% | 27.65% | 26.09% | 27.99% |
D&A For EBITDA | 1,057 | 1,031 | 927.12 | 872.6 | 844.17 | 810.78 |
EBIT | 3,467 | 3,344 | 2,890 | 2,499 | 1,816 | 1,724 |
EBIT Margin | 21.10% | 21.09% | 21.08% | 20.49% | 17.81% | 19.04% |
Effective Tax Rate | 24.80% | 24.94% | 24.72% | 24.34% | 25.42% | 25.89% |
Revenue as Reported | 16,729 | 16,139 | 13,932 | 12,405 | 10,357 | 9,178 |
Advertising Expenses | - | 151.11 | 94.32 | 82.6 | - | - |